Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.81 |
| ▸ | TP53 | P04637 | 1/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.81 |
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.81 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.81 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.80 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.72 |
| ▸ | LSS | P48449 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17238748 | 1.00 | SLC22A1 (0.87) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL11424947 | 1.00 | SLC22A1 (0.87) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL17238753 | 1.00 | SLC22A1 (0.87) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL11416444 | 1.00 | SLC22A1 (0.87) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrapentylammonium SCHEMBL11428806 | 0.97 | SLC22A1 (0.86) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5304777 | 0.93 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5296604 | 0.93 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5284365 | 0.93 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL22806629 | 0.93 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5302268 | 0.93 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3330311-B1 | STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION | EVONIK OPERATIONS GMBH (DE) | 2021-05-05 | — | — | EP | claimed |
| US-10626236-B2 | Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom | EVONIK OPERATIONS GMBH (DE) | 2020-04-21 | — | — | US | claimed |
| US-20180155515-A1 | STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM | EVONIK OPERATIONS GMBH (DE) | 2018-06-07 | — | — | US | claimed |
| US-10793664-B2 | Process for preparing trimers and/or oligomers of diisocyanates | EVONIK OPERATIONS GMBH (DE) | 2020-10-06 | — | — | US | disclosed |
| US-10626236-B2 | Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom | EVONIK OPERATIONS GMBH (DE) | 2020-04-21 | — | — | US | disclosed |
| US-10336856-B2 | Alkoxysilane- and allophanate-functionalized coating materials | EVONIK DEGUSSA GMBH (DE) | 2019-07-02 | — | — | US | disclosed |
| US-20180327538-A1 | PROCESS FOR PREPARING TRIMERS AND/OR OLIGOMERS OF DIISOCYANATES | EVONIK OPERATIONS GMBH (DE) | 2018-11-15 | — | — | US | disclosed |
| US-20180312713-A1 | Coating compositions comprising monoallophanates based on alkoxysilane alkyl isocyanates | EVONIK DEGUSSA GMBH (DE) | 2018-11-01 | — | — | US | disclosed |
| US-10093826-B2 | Alkoxysilane-functionalized allophanate-containing coating compositions | EVONIK DEGUSSA GMBH (DE) | 2018-10-09 | — | — | US | disclosed |
| US-20180155515-A1 | STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM | EVONIK OPERATIONS GMBH (DE) | 2018-06-07 | — | — | US | disclosed |
| US-9902095-B2 | Production of fibre composite component part based on steel and polyurethane | EVONIK DEGUSSA GMBH (DE) | 2018-02-27 | — | — | US | disclosed |
| US-9902096-B2 | Production of fibre composite component part based on aluminium and polyurethane | EVONIK DEGUSSA GMBH (DE) | 2018-02-27 | — | — | US | disclosed |
| US-20170369631-A1 | ALKOXYSILANE- AND ALLOPHANATE-FUNCTIONALIZED COATING MATERIALS | EVONIK DEGUSSA GMBH (DE) | 2017-12-28 | — | — | US | disclosed |
| US-20170369736-A1 | ALKOXYSILANE-FUNCTIONALIZED ALLOPHANATE-CONTAINING COATING COMPOSITIONS | EVONIK DEGUSSA GMBH (DE) | 2017-12-28 | — | — | US | disclosed |
| US-20150321393-A1 | PRODUCTION OF FIBRE COMPOSITE COMPONENT PART BASED ON ALUMINIUM AND POLYURETHANE | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20150321392-A1 | PRODUCTION OF FIBRE COMPOSITE COMPONENT PART BASED ON STEEL AND POLYURETHANE | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336856-B2 | Alkoxysilane- and allophanate-functionalized coating materials | DDAH1, OR10J3, AP3S1 | SLC22A1 1697/4885ALDH1A1 457/4885TP53 3754/4885 |
| US-10093826-B2 | Alkoxysilane-functionalized allophanate-containing coating compositions | DDAH1, OR10J3, AP3S1 | SLC22A1 2137/4885ALDH1A1 742/4885TP53 4625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.